Metro-Minnesota Community Clinical Oncology is a clinical research site located in Saint Louis Park, Minnesota, United States 55426.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
Metro-Minnesota Community Clinical Oncology has participated in 4 clinical trials with 4 currently active.
Therapeutic areas: Triple-Negative Breast Cancer, Renal Cell Carcinoma, Breast Neoplasms.
Sponsors: Merck Sharp & Dohme LLC, Eli Lilly and Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Minnesota · View every site in Saint Louis Park
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Metro-Minnesota Community Clinical Oncology has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Metro-Minnesota Community Clinical Oncology has 4 clinical trials on record, with 4 currently active. Their work covers Triple-Negative Breast Cancer, Renal Cell Carcinoma, Breast Neoplasms.
Metro-Minnesota Community Clinical Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.